Stock JENBURPH6 JENBURKT PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Jenburkt Pharmaceuticals Limited

Equities

JENBURPH6

INE354A01013

Market Closed - Bombay S.E.
Other stock markets
 06:00:57 2024-07-04 EDT 		5-day change 1st Jan Change
878.4 INR -0.02% Intraday chart for Jenburkt Pharmaceuticals Limited +1.53% +29.15%
05-28 Jenburkt Pharmaceuticals Limited Announces Board Retirements CI
05-28 Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jenburkt Pharmaceuticals Limited Announces Board Retirements
CI
Jenburkt Pharmaceuticals Limited Announces Dividend
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as A Non-Executive and Independent Director
CI
Jenburkt Pharmaceuticals Limited Appoints Sumit Ajaybhai Thakkar as Non-Executive Independent Director
CI
Jenburkt Pharmaceuticals Limited Approves Dividend for the Financial Year Ended 31 March, 2023
CI
Ex-dividend day for final dividend
FA
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Jenburkt Pharmaceuticals Limited Approves Dividend
CI
Tranche Update on Jenburkt Pharmaceuticals Limited's Equity Buyback Plan announced on December 1, 2022.
CI
Jenburkt Pharmaceuticals Limited's Equity Buyback announced on December 1, 2022, has closed with repurchase of 176,078 shares, representing 3.84% for INR 114.24 million.
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Jenburkt Pharmaceuticals Limited announces an Equity Buyback for INR 116 million worth of its shares.
CI
Jenburkt Pharmaceuticals Limited authorizes a Buyback Plan.
CI
Jenburkt Pharmaceuticals Board to Consider Share Buyback
MT
Jenburkt Pharmaceuticals Limited's Board intends to launch an Equity Buyback on December 1, 2022.
CI
Jenburkt Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JENBURPH6 Stock
  4. News Jenburkt Pharmaceuticals Limited